Allianz SE
ALIZY
OTC PK
Weiss Ratings | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | C | |||
Rating Factors | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Very Weak | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.76 | |||
Price History | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 4.20% | |||
30-Day Total Return | 13.97% | |||
60-Day Total Return | 11.67% | |||
90-Day Total Return | 26.65% | |||
Year to Date Total Return | 11.99% | |||
1-Year Total Return | 39.87% | |||
2-Year Total Return | 38.13% | |||
3-Year Total Return | 32.81% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -1.21% | |||
52-Week Low % Change | 38.88% | |||
Price | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $29.70 | |||
52-Week Low Price | $21.13 | |||
52-Week Low Price (Date) | May 31, 2023 | |||
52-Week High Price (Date) | Mar 20, 2024 | |||
Valuation | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 115.56B | |||
Enterprise Value | 136.13B | |||
Price/Earnings (TTM) | 2.64 | |||
Earnings Per Share (TTM) | 11.11 | |||
Earnings Per Share Growth | -33.45% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.16 | |||
Price/Book (Q) | 0.18 | |||
Enterprise Value/Revenue (TTM) | 1.95 | |||
Price | $29.94 | |||
Enterprise Value/EBITDA (TTM) | 21.98 | |||
Enterprise Value/EBIT | 25.63 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 391.99M | |||
Dividend Yield | 2.96% | |||
Div. Per Share (Most Recent) | $0.87 | |||
Dividend Per Share (TTM) | $0.87 | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $0.87 | |||
Company Info | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 49 89 3800 0 | |||
Address | -- | |||
Website | www.allianz.com | |||
Country | Germany | |||
Year Founded | 1890 | |||
Profitability | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $178.13 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | 47.51% | |||
Earnings Growth (Q YOY) | 33.39% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 38.78% | |||
Balance Sheet | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 125.74B | |||
Cash Per Share (Q) | $320.78 | |||
Total Current Assets (Q) | 189.77B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 70.28B | |||
Current Ratio (Q) | 7.707 | |||
Book Value Per Share (Q) | $165.12 | |||
Total Assets (Q) | 1.09T | |||
Total Current Liabilities (Q) | 24.62B | |||
Total Debt (Q) | 36.21B | |||
Total Liabilities (Q) | 1.02T | |||
Total Common Equity (Q) | 64.64B | |||
Cash Flow | ALIZY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||